Figure 1.
Flow chart of study selection. *Conditions affecting platelet aggregation: physical or psychological stress, acute cardiovascular disease or pregnancy. †In vitro was defined as studies in which β-blockers were added after blood drawing. ‡No outcome measures and/or no measure of variability (SE or SD), t statistic or exact P value reported